Inventor
BURKAMP FRANK
GB20 patents
⚠️ This page may combine multiple inventors who share the name “BURKAMP FRANK”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
ALMAC DISCOVERY LTD
9 patentsUS9714244B2Jul 25, 2017
Substituted pyrido[4,3-d]pyrimidines as Wee-1 inhibitors
ALMAC DISCOVERY LTD2 citations67
US11053213B2Jul 6, 2021
Pharmaceutical compounds
ALMAC DISCOVERY LTD5 citations66
US9850247B2Dec 26, 2017
Pyrimidopyrimidinones useful as Wee-1 kinase inhibitors
ALMAC DISCOVERY LTD5 citations64
US10766903B2Sep 8, 2020
Piperidine derivatives as inhibitors of ubiquitin specific protease 7
ALMAC DISCOVERY LTD3 citations63
US11208413B2Dec 28, 2021
Pyrimidopyrimidinones useful as wee-1 kinase inhibitors
ALMAC DISCOVERY LTD1 citations59
US12466805B2Nov 11, 2025
Pharmaceutical compounds
ALMAC DISCOVERY LTD0 citations56
US11807646B2Nov 7, 2023
4-hydroxypiperidine derivatives and their use as inhibitors of ubiquitin specific protease 19 (USP19)
ALMAC DISCOVERY LTD1 citations51
US9156853B2Oct 13, 2015
AKT inhibitor compounds for treatment of cancer
ALMAC DISCOVERY LTD1 citations46
US10766902B2Sep 8, 2020
Wee-1 inhibiting pyrazolopyrimidinone compounds
ALMAC DISCOVERY LTD0 citations34
MERCK SHARP & DOHME
6 patentsUS6852718B2Feb 8, 2005
Phenylsulphonylipiperazinyl derivatives as 5-HT receptor ligands
MERCK SHARP & DOHME35 citations90
US6559166B1May 6, 2003
Phenylsulphonyl derivatives as 5-HT receptor ligands
MERCK SHARP & DOHME14 citations82
US7449585B2Nov 11, 2008
Indazol-3-ones and analogues and derivatives thereof which modulate the function of the vanilloid-1 receptor (VR1)
MERCK SHARP & DOHME2 citations62
US7329659B2Feb 12, 2008
Substituted-1-phthalazinamines as vr-1 antagonists
MERCK SHARP & DOHME2 citations61
US7442701B2Oct 28, 2008
Amino-heterocycles as VR-1 antagonists for treating pain
MERCK SHARP & DOHME6 citations60
US6777430B2Aug 17, 2004
Phenylsulphonyl derivatives as 5-HT receptor ligands
MERCK SHARP & DOHME2 citations60